FIELD: organic chemistry, medicine. SUBSTANCE: invention proposes the use of 2-ethyl-6-methyl-3-hydroxypyridine succinate as myeloprotective agent for prophylaxis and correction of cytopenic syndrome. Agent prevents impairment of hemopoietic cells differentiation process. EFFECT: valuable medicinal property of agent. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIOXIDANT, ANTIHYPERGLYCEMIC, HYPOLIPIDEMIC AND ANTISHOCK N-ACETYLCYSTEINATE 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE | 2006 |
|
RU2357955C2 |
PREPARATION FOR TREATMENT OF OBLITERATING ATHEROSCLEROSIS OF LOWER LIMB VESSELS AND METHOD FOR ITS TREATMENT | 2001 |
|
RU2190404C1 |
HEPATOPROTECTOR PREPARATION FOR PROPHYLAXIS AND CORRECTION OF TOXIC HEPATIC LESIONS | 2001 |
|
RU2189817C1 |
METHOD FOR STIMULATING MYELOGENESIS | 2010 |
|
RU2442589C1 |
METHOD FOR MODELING STOMACH AND INTESTINE ULCERATION | 2004 |
|
RU2269161C2 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
DRUG SHOWING ANXIOLYTIC, ANTIALCOHOLIC AND CEREBROPROTECTIVE EFFECTS | 1999 |
|
RU2145855C1 |
ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
Authors
Dates
2002-12-10—Published
2001-03-05—Filed